Evidence map›Paper›PMID 36323693›Full record

ArticleNature communications2022

Reactive astrocytes transduce inflammation in a blood-brain barrier model through a TNF-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin.

Hyosung Kim, Kun Leng, Jinhee Park, Alexander G Sorets, Suil Kim, Alena Shostak, Rebecca J Embalabala, Kate Mlouk, Ketaki A Katdare, Indigo V L Rose and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 2 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 2 syntheses or guidelines pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Astrocyte-driven multicellular mechanisms of CNS repair and cerebroprotection.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Biochemistry and biophysics reports · 2026
    Review

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Hyosung KimDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Kun LengInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0001-9931-1375
Jinhee ParkDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.
Alexander G SoretsDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.
Suil KimVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, USA.
Alena ShostakDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Rebecca J EmbalabalaVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, USA.
Kate MloukVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, USA.
Ketaki A KatdareVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0001-9345-7592
Indigo V L RoseInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0003-0491-1269
Sarah M SturgeonDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Emma H NealDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Yan AoDepartment of Neurobiology, University of California, Los Angeles, Los Angeles, CA, USA.
Shinong WangDepartment of Neurobiology, University of California, Los Angeles, Los Angeles, CA, USA.
Michael V SofroniewDepartment of Neurobiology, University of California, Los Angeles, Los Angeles, CA, USA.ORCID 0000-0001-6075-0178
Jonathan M BrungerDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.
Douglas G McMahonVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, USA.
Matthew S SchragVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, USA.
Martin KampmannInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-3819-7019
Ethan S LippmannDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA. ethan.s.lippmann@vanderbilt.edu.ORCID 0000-0001-5703-5747
Vanderbilt University · USUniversity of California, Los Angeles · USUniversity of California, San Francisco · USVanderbilt University Medical Center · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced GenomicsG20RR030956 · NCRR · VANDERBILT UNIVERSITY · PI PIETENPOL, JENNIFER A · 2010 to 2010
$8.7M
Vanderbilt Interdisciplinary Training Program in Alzheimer's DiseaseT32AG058524 · NIA · VANDERBILT UNIVERSITY · PI ANGELA L. JEFFERSON · 2018 to 2026
$3.5M
Predoctoral Training in NeurobiologyT32NS115706 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SAMUEL JEREMY PLEASURE · 2020 to 2026
$3.4M
Injectable biomaterial depots to manipulate scar and foster axon growth after SCIR01NS084030 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SOFRONIEW, MICHAEL V · 2014 to 2023
$3.0M
STAT3 activation in astrocytes as a driver of neurovascular dysfunction in Alzheimer's disease and related dementiasRF1NS129735 · NINDS · VANDERBILT UNIVERSITY · PI LIPPMANN, ETHAN, SCHRAG, MATTHEW · 2022 to 2023
$2.5M
Neurobiology of the Circadian ClockR01GM117650 · NIGMS · VANDERBILT UNIVERSITY · PI MCMAHON, DOUGLAS G · 2015 to 2023
$2.1M
Defective lysosomal membrane fission mediates axonal lysosome accumulation in dystrophic neurites in Alzheimer's disease.K76AG060001 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SCHRAG, MATTHEW · 2019 to 2023
$1.2M
NCATS NIH HHS UL1 TR002243NCI NIH HHS P30 CA068485NCRR NIH HHS G20 RR030956NCRR NIH HHS UL1 RR024975NEI NIH HHS P30 EY008126NIA NIH HHS F30 AG066418NIA NIH HHS K76 AG060001NIA NIH HHS R21 AG070859NIA NIH HHS T32 AG058524NICHD NIH HHS P50 HD103537NIGMS NIH HHS R01 GM117650NINDS NIH HHS R01 NS084030NINDS NIH HHS RF1 NS129735NINDS NIH HHS T32 NS115706
6 · The paper itself

Abstract

Astrocytes are critical components of the neurovascular unit that support blood-brain barrier (BBB) function. Pathological transformation of astrocytes to reactive states can be protective or harmful to BBB function. Here, using a human induced pluripotent stem cell (iPSC)-derived BBB co-culture model, we show that tumor necrosis factor (TNF) transitions astrocytes to an inflammatory reactive state that causes BBB dysfunction through activation of STAT3 and increased expression of SERPINA3, which encodes alpha 1-antichymotrypsin (α1ACT). To contextualize these findings, we correlated astrocytic STAT3 activation to vascular inflammation in postmortem human tissue. Further, in murine brain organotypic cultures, astrocyte-specific silencing of Serpina3n reduced vascular inflammation after TNF challenge. Last, treatment with recombinant Serpina3n in both ex vivo explant cultures and in vivo was sufficient to induce BBB dysfunction-related molecular changes. Overall, our results define the TNF-STAT3-α1ACT signaling axis as a driver of an inflammatory reactive astrocyte signature that contributes to BBB dysfunction.

Indexed as

Blood-Brain BarrierInduced Pluripotent Stem Cellsalpha 1-AntichymotrypsinAnimalsAstrocytesCells, CulturedHumansInflammationMiceSTAT3 Transcription FactorTumor Necrosis Factor-alphaalpha 1-AntichymotrypsinSTAT3 protein, humanSTAT3 Transcription FactorTumor Necrosis Factor-alpha

Identifiers

PMID36323693
PMCPMC9630454
OpenAlexW4308147217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.